Kymera Therapeutics
KYMR
#1949
Rank
HK$77.16 B
Marketcap
HK$903.87
Share price
-3.42%
Change (1 day)
75.87%
Change (1 year)

EPS for Kymera Therapeutics (KYMR)

EPS in 2026 (TTM): -HK$28.33

According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$28.38. In 2025 the company made an earnings per share (EPS) of -HK$28.85 a decrease over its 2024 EPS that were of -HK$23.28.

EPS history for Kymera Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$28.33-1.78%
2025-HK$28.8523.91%
2024-HK$23.2817.86%
2023-HK$19.75-12.5%
2022-HK$22.5839.81%
2021-HK$16.1522.84%
2020-HK$13.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58-62.71%๐Ÿ‡บ๐Ÿ‡ธ USA